Richard Payerchin

Public benefit corporation announces developments for 2025.

Research estimates health care spending by conditions, age, types of care, down to county level.

Bargaining for widely used prescription drugs may save money for Medicare, but AAR wants seniors to see better prices at the pharmacy counter.

With high demand but high prices for antiobesity drugs, patients may fall for phony pharmaceuticals.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

House Ways and Means Committee considers suggestions on Making America Healthy Again.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

What new treatments mean for practices and patients.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Primary care, oncology can use team approach to improve prevention and screening efforts.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Congress could rectify the situation in upcoming spending bill or with pending legislation.

Legislators question Health and Human Services leaders about potential for wrongful disclosure of private health information.

Other clinicians and patients all have a place in slowing the spread of antimicrobial resistance.

Screenings are also crucial, but prior authorization requirements create a barrier to care.

Gallup, Emory University post findings about highest priorities for government leaders right now.

Agency logs national data for transition month between Biden and Trump administrations.

A family medicine specialist who works with cancer survivorship explains a study that shows how vital screenings are for patients.

An expert on antimicrobial resistance discusses how it involves patients in local doctors’ offices and around the world.

WSJ: Department of Government Efficiency examines payment and contracting systems.

Comments on 2026 rule include suggestions on behavioral health, AI and more.

A physician expert discusses antimicrobial resistance across all of health care, and how primary care physicians can help.

An analysis by Gibbins Advisors.

Steward Health Care tops list as biggest hospital sector bankruptcy in decades, analyst says.

A slideshow with statements of support.

Legislation could counter total 6.43% budget cut, but time is ticking away, doctors say.